V
LIVE

Serial Number

79294440

Owner

Vectura Limited

Attorney

Molly B. Markley

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

V Trademark

Serial Number: 79294440 • Registration: 6504530

V is a trademark filed by Vectura Limited on August 3, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Vectura Limited (17 trademarks)

1 Prospect West
Chippenham, Wiltshire SN146FH , GB

Entity Type: 99

Trademark Details

Filing Date

August 3, 2020

Registration Date

October 5, 2021

Published for Opposition

July 20, 2021

Goods & Services

Medical preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; biological preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for treating pulmonary diseases via inhalation; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems

Chemical additives for use in the manufacture of medical preparations

Medical apparatus and instruments, namely inhalers; drug delivery devices, namely inhalers; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; component parts and fittings for all the aforesaid goods

Scientific research relating to medical preparations and drug delivery devices; development and design medical preparations and drug delivery devices; analysis, and investigation in the form of testing of medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 8, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 21, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 21, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jul 19, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
ASSIGNED TO LIE
Jun 15, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 3, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2020 REPR